Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching Efavirenz to Raltegravir for Endothelial Function in HIV
NCT01270802Phase 4Completed
- Sponsor
- Indiana University
- Start
- Apr 2011
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of raltegravir in human immunodeficiency virus infection (HIV), sponsored by Indiana University. Started Apr 2011; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01270802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01270802.